Showing posts with label Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. Show all posts
Showing posts with label Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. Show all posts

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

Labels:
Subscribe to: Posts (Atom)

Upcoming Long Island Event

Upcoming Long Island Event
DOO-WOP CONCERT FOR OVARIAN CANCER